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Hypoxia regulates PDGF-B interactions between glomerular
capillary endothelial and mesangial cells.
Background. Platelet-derived growth factor (PDGF)-B reg-
ulates mesangial cell and vessel development during embryo-
genesis, and contributes to the pathogenesis of adult renal and
vascular diseases. Endothelial cell PDGF-B exerts paracrine ef-
fects on mesangial cells, but its regulation is not well defined.
We examined the impact of hypoxia on PDGF-B–mediated in-
teractions between glomerular endothelial and mesangial cells,
a condition of potential relevance in developing, and diseased
adult, kidneys.
Methods. Glomerular endothelial or mesangial cells were
subjected to hypoxia and responses compared to normoxic cells.
Endothelial PDGF-B was studied by Northern and Western
analysis. Mesangial proliferative responses to PDGF-B were
assessed by 3H-thymidine incorporation, and migration by a
modified Boyden chamber assay. Hypoxia-induced changes in
receptor specific binding capacity were studied by saturation
binding assays.
Results. Hypoxia stimulated increases in endothelial PDGF-
B mRNA and protein. In normoxic mesangial cells, PDGF-B
stimulated dose-dependent proliferation, but the proliferative
response of hypoxic cells was two to three times greater. Ex-
ogenous PDGF-B also caused prompter migration in hypoxic
mesangial cells. Mesangial cells were treated with endothe-
lial cell-conditioned medium. More cells migrated when hy-
poxic cells were stimulated with hypoxic conditioned medium,
than when normoxic cells were stimulated with normoxic
conditioned medium. Preincubating conditioned medium with
PDGF-B neutralizing antibody greatly decreased the chemoat-
tractant activity. Binding studies demonstrated increased spe-
cific binding capacity in hypoxic cells.
Conclusion. Hypoxia enhances PDGF-B paracrine inter-
actions between glomerular endothelial and mesangial cells.
These hypoxia-regulated interactions may be important dur-
ing glomerulogenesis in fetal life and during the pathogenesis
of adult glomerular disease.
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The cytokine platelet-derived growth factor (PDGF)-
B plays a critical role in glomerular maturation and blood
vessel formation during embryonic life, and contributes
to the pathogenesis of adult diseases such as glomeru-
losclerosis and atherosclerosis. Studies in mice lacking
PDGF-B demonstrated its importance during normal
embryogenesis [1]. Microaneurysms were noted in nu-
merous capillary beds, including the glomerulus, which
totally lacked mesangial cells. The aneurysmal dilatations
were attributed to the absence of perivascular cells, such
as mesangial cells, which provide structural support for
developing blood vessels [2].
In the developing kidney, PDGF-B appears to act
in a paracrine fashion. Lindahl et al [3] demonstrated
by in situ hybridization that endothelial cells invading
the cleft of the developing glomerulus expressed tran-
scripts for PDGF-B, but not the PDGF-b receptor. Con-
versely, mesangial cell precursors expressed mRNA only
for the PDGF-b receptor. The authors therefore hypoth-
esized that glomerular endothelial cell PDGF-B acts in
a paracrine fashion on adjacent mesangial cells, allow-
ing for comigration and localization of these cells to the
glomerulus. Although PDGF-B also is produced by fe-
tal podocytes and by mesangial cells themselves [4], the
requirement for endothelial PDGF-B in mesangial cell
development was recently demonstrated [5]. Mice lack-
ing endothelial PDGF displayed a renal phenotype rem-
iniscent of the pdgf−/− mice (i.e., absent or markedly
reduced numbers of mesangial cells). Further support-
ing these results, absence of glomerular endothelial cells
in mutant cloche zebrafish [6] or in Notch2del1 mice [7]
was associated with the lack of detectable mesangial
cells. Thus, endothelial cell-derived PDGF-B is critical
for mesangial cell development.
It is not currently understood what regulates the ex-
pression of PDGF-B in the nascent glomerular capillaries
during renal development. Of the many inducers that reg-
ulate PDGF-B, some, such as transforming growth factor-
b (TGF-b) [8] and basic fibroblast growth factor (bFGF)
[9], also play important roles during embryogenesis.
Low tissue oxygen tension during fetal life stimulates
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angiogenesis, and hypoxia potently induces PDGF-B
gene transcription in human umbilical vein endothelial
cells (HUVECs) [10] and pulmonary artery endothelial
cells [11]. Although as yet no reports have described a
similar response in glomerular capillary endothelial cells,
it is important to note that Freeburg et al [12, 13] demon-
strated that the developing kidney stained positive for
pimonidazole hydrochloride, a marker which becomes
detectable under conditions of severe hypoxia.
While PDGF-B is essential for normal embryonic ves-
sel formation, the cytokine also plays a pathogenic role
in renal diseases of the mature kidney. PDGF-B stimu-
lates mesangial cell proliferation, which in turn, leads to
increased matrix production and ultimately glomeru-
losclerosis. In the Thy 1 model of mesangioproliferative
nephritis, PDGF-B transcripts and protein are increased
in the glomeruli of diseased rats [14–16]. We demon-
strated that infusion of PDGF-B recapitulated these find-
ings [17]; and administration of PDGF-B neutralizing
antibody abrogated glomerulosclerosis [18], supporting
an etiologic function for PDGF-B. In human glomeru-
lar disease characterized by mesangial cell proliferation,
PDGF-B also appears to play a role (reviewed in [19]).
PDGF-B is regulated by effectors in pathogenic path-
ways, such as thrombin [20], tumor necrosis factor (TNF)
[21], interleukin (IL)-6 [22], and high glucose [23]. How-
ever, the impact of hypoxia on PDGF-mediated mesan-
gial cell responses in renal diseases has not been studied.
There has been increased recognition of endothelial cell
damage in progressive renal diseases (reviewed in [24])
and glomerular hypoxia may occur as a consequence of
loss of the microvasculature or from microthrombus for-
mation. In several animal models of glomerular disease,
the loss of glomerular endothelium correlates with the
development of sclerosis [25, 26].
Since low oxygen tension appears to be present in
the developing kidney and hypoxia may be present in
glomerular diseases in the adult, we investigated whether
hypoxia is a regulator of PDGF-B interactions between
glomerular capillary endothelial and mesangial cells. Our
results demonstrate that hypoxia increases glomerular
capillary endothelial cell PDGF-B and that hypoxia en-
hances mesangial cell proliferation and migration in re-
sponse to PDGF-B. We further show that while hypoxia
does not increase total cellular PDGF-b receptor levels,
it results in increased specific binding capacity.
METHODS
Cells
Bovine glomerular capillary endothelial (CH1a) cells
were isolated from the kidneys of calves less than
1 year old, using a modification of a previously de-
scribed [27] method. Glomeruli from cortical slices were
isolated by sieving, then digested with type IV colla-
genase (Worthington Biochemical Corp., Freehold, NJ,
USA). Glomerular digests were plated onto plastic cul-
ture dishes coated with 0.2% gelatin (Sigma Chemical
Co., St. Louis, MO, USA) and incubated with 20% fe-
tal bovine serum (FBS) in RPMI-1640 medium with
12 lg/mL bovine brain extract (Clonetics, San Diego,
CA, USA), 10 ng/mL acidic FGF (R&D Systems, Min-
neapolis, MN, USA), 2.6 lg/mL heparin, 1100 U/mL
penicillin-100 lg/mL streptomycin, and 2.5 lg/mL am-
photericin. Amphotericin was removed from the media
after 2 to 3 weeks. When dishes were approximately 60%
to 70% confluent, cells were incubated for 3 hours with
10 lg/mL DiI-labeled acetylated low-density lipopro-
tein (ac-LDL) (BTI, Stoughton, MA, USA). Cells were
trypsinized, sorted by fluorescence-activated cell sort-
ing (FACS) using sterile techniques and postsort anal-
ysis was performed on positive cells. Ac-LDL–positive
cells were plated on dishes as above, and growth medium
was changed three times per week. One week after ac-
LDL–positive cells were plated, penicillin in the growth
medium was reduced to 200 U/mL. Cells were con-
firmed as endothelial by classical morphology, positive
immunostaining for von Willebrand factor (vWF) (Dako,
Carpinteria, CA, USA), and negative staining for alpha
smooth muscle actin (a-SMA) (Sigma Chemical Co.).
Medium was changed three times per week, and cells
were used between passages 5 and 20.
Rat mesangial cells were isolated from glomerular di-
gests isolated through sieving as above. Cells were con-
firmed as mesangial by positive a-SMA and negative
vWF immunostaining. Cells were maintained in 15% FBS
in RPMI-1640, with 2 mmol/L L-glutamine, 15 mmol/L
Hepes buffer, 1 mmol/L sodium pyruvate, 1 mg/mL
sodium bicarbonate, 8 lg/mL insulin, and 92 lg/mL D-
valine. Medium was changed three times per week, and
cells were used up to passage 22.
Hypoxia experiments
Cells maintained under normoxic conditions were in-
cubated in standard humidified 5.5% CO2 incubators
(21% O2). Hypoxic conditions (1.5% or 3% O2, 5% CO2,
balance nitrogen) were achieved in a humidified vari-
able aerobic workstation (InVIVO2) (Ruskinn Technol-
ogy, Leeds, UK) or in modular sealed hypoxia chambers
(Billups-Rothenberg, Inc., Del-Mar, CA, USA) filled
with premixed gases.
Northern analysis
Glomerular capillary endothelial CH1a cells in conflu-
ent 100 mm dishes were incubated overnight in medium
containing 0.5% FBS, then transferred to hypoxic cham-
bers. After hypoxic exposure from 1 to 32 hours, cells
were lysed in Trizol (Gibco BRL Life Technologies,
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Gaithersburg, MD, USA) and total RNA isolated ac-
cording to the manufacturer’s directions. Time-matched
controls were cells maintained in normoxia. Ten mi-
crograms total RNA per sample were resolved on a
1% agarose gel, followed by capillary blotting trans-
fer to a nylon membrane. Membranes were prehy-
brized at 65◦C in Rapid Hyb (Amersham, Piscataway,
NJ, USA), hybridized overnight with the appropriate
32P-deoxycytidine triphosphate (dCTP)–labeled probe,
then washed. Steps conducted at 65◦C for cDNA probes
were conducted at 42◦C for oligonucleotide probes. The
blots were then exposed to Kodak X-AR film (Eastman
Kodak, Rochester, NY, USA) and analyzed us-
ing the PhosphorImage system (Molecular Dynamics,
Sunnyvale, CA, USA).
The following probes were used: a 2.0 kb PDGF-
B cDNA probe isolated from pcDU1, a 2.1 kb vas-
cular endothelial growth factor (VEGF) cDNA probe
isolated from pT7T3D-Pac (both from American Type
Culture Collection, Rockville, MD, USA), and an
oligonucleotide 18S rRNA probe (Integrated DNA Tech-
nology, Coralville, IA, USA). cDNA probes were labeled
using a random priming system (Invitrogen, Carlsbad,
CA, USA or Amersham) and oligonucleotide probes
using terminal deoxynucleotidyl transferase (Life Tech-
nologies). Densitometry was performed using the Image-
Quant software program (Molecular Dynamics).
Immunoblotting
Quiescent endothelial cells in 100 mm dishes were sub-
jected to hypoxia as before. Dishes were rinsed twice with
cold phosphate-buffered saline (PBS), then snap-frozen
in liquid nitrogen. After rapidly thawing in a 37◦C water
bath, cells were lysed in RIPA buffer [50 mmol/L Tris-
HCl, pH 7.4, 1% NP-40, 0.25% sodium deoxycholate,
150 mmol/L NaCl, 1 mmol/L ethylenediaminetetraacetic
acid (EDTA), 1 mmol/L phenylmethylsulfonyl fluoride
(PMSF), 1 lg/mL each of aprotinin, leupeptin, and pep-
statin, 1 mmol/L sodium orthovanadate, and 1 mmol/L
sodium fluoride]. In other experiments, nuclear extracts
were isolated as previously described [28]. Briefly, thawed
cell lysates were incubated in water with 0.03% igepal
(Sigma Chemical Co.) and protease inhibitors for 15 min-
utes on ice. Samples were pelleted at 14,000 × g, the su-
pernatant removed and nuclei lysed in 20 mmol/L Hepes,
25% glycerol, 420 mmol/L NaCl, 1.5 mmol/L magnesium
chloride, and 0.2 mmol/L EDTA. Nuclear proteins were
obtained following a second brief centrifugation.
Ten to 25 micrograms of protein per sample were
electrophoresed through acrylamide gels, then trans-
ferred to polyvinylidene fluoride (PVDF) membranes,
and blocked for 1 hour at room temperature with 3%
bovine serum albumin (BSA) (Midwest Scientific, St.
Louis, MO, USA) or 5% milk (Bio-Rad, Hercules, CA,
USA). Membranes were incubated overnight at 4◦C
with primary antibody, and for 1 hour at room tem-
perature with the appropriate horseradish peroxidase–
conjugated secondary antibody. Proteins were analyzed
using the chemiluminescence technique (Amersham; or
Pierce Biotechnology, Rockford, IL, USA). Primary an-
tibodies included rabbit polyclonal antibodies to hu-
man PDGF-B, PDGF-b receptor, nuclear factor-jB
(NF-kB), c-jun (Santa Cruz Biotechnology, Santa Cruz,
CA, USA), and hypoxia-inducible factor-1a (HIF-1a(
(Novus Biologicals, Littleton, CO, USA). Secondary an-
tibodies were horseradish peroxidase–conjugated an-
tibodies against the appropriate species (Santa Cruz
Biotechnology).
Assessment of proliferation
Confluent mesangial cells plated into 24-well culture
dishes were quiesced in serum-free medium for 48 hours.
Cells were then transferred to hypoxic chambers or main-
tained in normoxia as above and stimulated with varying
concentrations of PDGF-BB (R&D Systems) or vehicle
for 24 hours. Incorporation of 3H-thymidine following a
4-hour pulse at the end of the 24-hour treatment was de-
termined. Each experiment consisted of six replicates of
each condition, and mean and standard deviation (SD)
were calculated for each experiment.
Migration assays
Confluent mesangial cells were maintained in serum-
free medium for 48 hours, then either subjected to hy-
poxia or maintained in normoxia for the last 24 hours.
Cells were trypsinized, and 50,000 cells resuspended in
2% serum were seeded onto 6.5 mm 8 lm pore polycar-
bonate transwell filters (Corning Costar, Corning, NY,
USA). The filters were placed into wells containing either
50 ng/mL PDGF-BB or vehicle. In other experiments, the
wells contained cell-free media conditioned by endothe-
lial cells, with or without pre-incubation with PDGF-B
neutralizing antibody (goat antihuman PDGF-BB, 0.1
lg/mL) or irrelevant goat IgG (0.1 lg/mL). Mesangial
cells were allowed to migrate, then filters were removed,
and the apical surface washed twice with PBS. Cells re-
maining on the apical surface were removed by gentle
swabbing with a cotton-tipped applicator. Cells that had
migrated to the undersurface of the filter were fixed,
Giemsa stained, and cells in nine consecutive central
fields at 200× magnification were counted.
Binding studies
Quiescent normoxic or hypoxic mesangial cells were
washed twice with PBS, then treated briefly with glycine
(20 mmol/L)-saline (125 mmol/L NaCl) buffer (pH 3.0)
to strip off any PDGF-B binding to surface receptors,
698 Eng et al: Hypoxia and PDGF-B interactions between glomerular cells
followed by two rinses with binding buffer (25 mmol/L
Hepes and 2 mg/mL BSA in RPMI, pH 7.4). Cells were
then incubated with varying concentrations of 125I-PDGF
(Amersham) for 2 hours at room temperature on an or-
bital shaker at 120 rpm. Hypoxic cells were maintained
in hypoxia for the incubation period. Cell-associated ra-
dioactivity was measured after lysing in solubilization
buffer containing 20 mmol/L Hepes, 0.1 mg/mL BSA,
and 1% Triton X-100 and 10% glycerol (vol/vol). Nonspe-
cific binding was determined as the amount of radioactiv-
ity binding in the presence of 300-fold excess unlabeled
PDGF-B. Binding data were analyzed with Prism4 soft-
ware (GraphPad Software, www.graphpad.com).
RESULTS
Isolation of bovine glomerular capillary endothelial
cells
Our attempts to isolate glomerular capillary endothe-
lial cells were successful in bovine, but not in rat,
glomeruli. Bovine capillary endothelial cells were iden-
tified from collagenase-digested glomeruli by uptake of
DiI-labeled ac-LDL and positive cells identified by FACS
were established in culture. Postsort analysis confirmed a
high degree of purity (typically 97%) and the endothelial
cell phenotype was further confirmed by typical morphol-
ogy, positive vWF and negative a-SMA staining. Cultures
remained 97% pure at passage 20, as assessed by repeat
FACS analysis. Previous methodologies to isolate en-
dothelial cells have employed double dilution cloning in
order to separate endothelial cells from other glomerular
cells, particularly mesangial cells [27]. Our use of FACS
sorting represents a substantial improvement in the time
and effort required for isolation of glomerular endothe-
lial cells.
Hypoxia increases glomerular capillary endothelial cell
PDGF-B
Northern blot analysis showed that steady state PDGF-
B transcripts increased after as little as 1 hour of hypoxia
and remained elevated compared to normoxic time-
matched controls through 32 hours of hypoxia (Fig. 1A).
Densitometric analysis of four independent experiments
(Fig. 1B) revealed up to a twofold increase in PDGF-
B message in hypoxic cells compared to normoxic time-
matched controls, although the timing of the increase var-
ied among experiments. In order to determine whether
the increase in steady-state levels of PDGF-B resulted
from increased gene transcription, we treated cells with
actinomycin D. Densitometry showed a similar degree
of reduction compared to controls in PDGF-B mRNA
levels from actinomycin D–treated normoxic or hypoxic
endothelial cells (Fig. 1C). These results raise the pos-
sibility of a transcriptional regulation of PDGF-B by
hypoxia.
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Fig. 1. Hypoxia increases gene transcription of platelet-derived
growth factor (PDGF)-B in glomerular capillary endothelial cells.
(A) Glomerular capillary endothelial cells were subjected to hypoxia
(1.5% O2) for the indicated hours (h). Changes in PDGF-B gene ex-
pression in hypoxic (H) and time-matched normoxic (N) cells compared
to controls harvested at the beginning of the experiment (C) were as-
sessed by Northern blotting. Blots were reprobed for 18S rRNA to
demonstrate equivalency of loading and transfer. (B) Northern blots
for PDGF-B were analyzed by densitometry and values expressed as
fold increase of normoxic control ± SD (N = 4). ∗P < 0.05 compared to
normoxic control. (C) Cells were incubated with actinomycin D during
the last 4 of 24 hours of hypoxia or normoxia and compared to ve-
hicle [dimethyl sulfoxide (DMSO)]-treated hypoxic or normoxic cells.
Controls were cells harvested at the beginning of the experiment. Den-
sitometry was performed on membranes blotted for PDGF-B mRNA.
Values are expressed as fold of control (cells at time zero) ± SD (N =
3). The decrements in PDGF-B transcripts after actinomycin treatment
were not statistically different between normoxia and hypoxia.
To assess whether hypoxia also increases PDGF-B pro-
tein, we immunoblotted whole cell lysates from glomeru-
lar endothelial cells exposed to 1 to 24 hours of hypoxia.
As seen in Figure 2, PDGF-B protein levels are increased
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Fig. 2. Hypoxia increases platelet-derived growth factor (PDGF)-B
protein in hypoxic glomerular capillary endothelial cells. Immunoblot
for PDGF-B in whole cell lysates from glomerular capillary endothelial
cells subjected to the indicated durations [hours (h)] of hypoxia (H),
compared to time-matched normoxic controls (N).
in hypoxic glomerular capillary endothelial cells, com-
pared to time-matched normoxic controls. The increase
in protein was seen at 2, 4, and 24 hours of hypoxia.
Coomassie staining demonstrated equal loading of sam-
ples (data not shown).
Although endothelial cells were subjected to 1.5% O2
up to 32 hours, cells were not toxic as demonstrated by
only a 1% difference in lactate dehydrogenase (LDH)
levels in hypoxic and normoxic cells (data not shown).
Additionally, although the levels of oxygen we studied
were low, other investigators have studied the effects of
similarly low oxygen in a number of cell types [29–31].
PDGF-B gene transcription in hypoxic endothelial cells
is not mediated by HIF-1a or VEGF
Because the PDGF-B gene promoter has putative HIF-
1a binding sites, we investigated whether HIF-1a was re-
sponsible for the up-regulation of PDGF-B in hypoxic
glomerular endothelial cells. We did not detect a differ-
ence in nuclear HIF-1a levels between normoxic and hy-
poxic cells (data not shown). To confirm our results, we
additionally stimulated normoxic endothelial cells with
desferrioximine, nickel, or cobalt chloride which are hy-
poxia mimetics that stabilize HIF-1a. Northern blot anal-
yses failed to demonstrate induction of PDGF-B message
in stimulated cells compared to controls (data not shown).
VEGF is a hypoxia-inducible cytokine, with its gene
transcription regulated by HIF-1a. Since VEGF also
regulates the expression of PDGF-B [32], we investi-
gated whether increased PDGF-B transcripts in hypoxic
endothelial cells were due to increased VEGF. We per-
formed Northern blots for VEGF on total RNA iso-
lated from cells exposed to hypoxia for 2 to 32 hours
and time-matched normoxic controls. We analyzed re-
sults from two independent experiments by densitome-
try, but as might be anticipated from the negative HIF-1a
data, VEGF levels were either the same, or modestly di-
minished in hypoxic endothelial cells (data not shown).
Hypoxia increases mesangial cell responsiveness to
exogenous PDGF-B
Because hypoxia of the glomerulus also would affect
mesangial cells, we further investigated whether hypoxia
influences the degree of PDGF-B responses in these
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Fig. 3. Hypoxia enhances proliferation in platelet-derived growth fac-
tor (PDGF)-B–stimulated mesangial cells. Serum-starved normoxic or
hypoxic were stimulated for 24 hours with the indicated doses of PDGF-
B. 3H-thymidine incorporation during the last 4 hours of PDGF-B stim-
ulation was determined, and values are expressed as fold of control
(nonstimulated) cells. Each condition was conducted in sextuplicate
wells. Data are mean of four independent experiments. ∗P = 0.01 com-
pared to time matched normoxic cells, t test.
cells. We first examined the proliferative response of
normoxic and hypoxic mesangial cells stimulated with
PDGF-B. We observed a dose-dependent increase in 3H-
thymidine incorporation in both normoxic and hypoxic
mesangial cells, but at higher doses, the magnitude of in-
crease was significantly higher in hypoxic cells (Fig. 3).
At 10 ng/mL, PDGF stimulated a 4.1 ± 0.42-fold in-
crease in 3H-thymidine incorporation in normoxic cells
compared to nontreated controls. However, hypoxic cells
stimulated with PDGF-B demonstrated an 8.6 ± 2.8-fold
increase in 3H-thymidine incorporation compared to un-
stimulated hypoxic controls. At 20 ng/mL, PDGF-B in-
duced a 6.1 ± 2.3-fold increase in normoxic cells, whereas
in hypoxic cells, it achieved a 20.0 ± 9.6-fold increase in
3H-thymidine incorporation. These differences in PDGF-
stimulated proliferation between normoxic and hypoxic
cells were significant (P = 0.01) (N = 4). We confirmed
these results by counting cells in untreated or PDGF-B–
stimulated normoxic and hypoxic mesangial cells. In two
independent experiments, whereas PDGF-B stimulation
increased cell number in both normoxia and hypoxia, the
increase in numbers of hypoxic cells was threefold higher
than in normoxic cells (data not shown).
To study whether a more modest degree of hypoxia
also increased mesangial cell proliferative responses to
PDGF-B, we performed dose-response experiments in
mesangial cells subjected to 3% oxygen. Similar to the
responses observed at 1.5% oxygen, PDGF-B stimulated
a two- to threefold higher incorporation of 3H-thymidine
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Fig. 4. Hypoxic mesangial cell migrate more promptly in response
to platelet-derived growth factor (PDGF)-B. Serum-starved normoxic
or hypoxic mesangial cells were seeded onto 8 lm pore transwell fil-
ters and allowed to migrate for the indicated times in response to 50
ng/mL PDGF-B in the basal chamber. Migrated cells were fixed, Giemsa
stained, counted in nine consecutive 200× central fields, and expressed
as fold ± SD of normoxic cells migrating at 30 minutes (N = 6).
in hypoxic, compared to normoxic, cells (N = 2) (data not
shown).
We next investigated whether hypoxia also increased
the chemotactic response of mesangial cells to PDGF-
B. As seen in Figure 4, hypoxic mesangial cells migrated
more promptly compared to normoxic controls. In six
independent experiments, hypoxic cells migrated more
promptly than normoxic controls with a mean 36-fold in-
crease in numbers of migrated cells at 30 minutes. The
number of migrated hypoxic cells was increased 6.4- and
twofold compared to normoxic controls at 60 and 90 min-
utes, respectively. Because both the time to migration and
numbers of migrated normoxic and hypoxic cells varied
among experiments, we were not able to demonstrate
statistical significance.
As with the glomerular endothelial cells, mesangial
cells tolerated the hypoxic conditions without toxicity, as
shown by the same negligible increase in LDH levels.
Hypoxia stimulates increased mesangial cell migration in
response to PDGF-B produced by hypoxic glomerular
capillary endothelial cells
In order to investigate the possibility of a hypoxia-
regulated PDGF-B paracrine interaction between
glomerular capillary endothelial and mesangial cells, we
studied the migration of mesangial cells stimulated with
medium conditioned by endothelial cells. As shown in
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Fig. 5. Hypoxia amplifies platelet-derived growth factor (PDGF)-B–
mediated paracrine interactions between glomerular capillary endothe-
lial and mesangial cells. Normoxic mesangial cells were allowed to
migrate for 1 hour through transwell filters placed over wells with con-
ditioned medium from normoxic endothelial cells, preincubated with
either PDGF-B neutralizing antibody [conditioned medium + antibody
(CM + Ab)] or vehicle [conditioned medium (CM)]. Hypoxic mesan-
gial cells were similarly allowed to migrate in response to conditioned
medium from hypoxic endothelial cells incubated with either neutral-
izing antibody or vehicle. Migrated cells were counted as in Fig. 4 and
are expressed as fold increase of normoxic cells migrating to normoxic
conditioned medium ± SEM (N = 5). ∗P < 0.0001 and ∗∗P < 0.05 com-
pared to normoxic cells migrating to normoxic conditioned medium;
∗∗∗P < 0.0001 compared to hypoxic cells migrating to hypoxic condi-
tioned medium.
Figure 5, conditioned medium from hypoxic endothe-
lial cells stimulated a significantly greater migration of
hypoxic mesangial cells than did medium from nor-
moxic endothelial cells when used to stimulate normoxic
mesangial cells (11.7 ± 5.5-fold increase) (N = 5) (P <
0.05). The major chemotactic factor in the hypoxic con-
ditioned medium appeared to be PDGF-B, since prein-
cubation of the medium with a neutralizing antibody to
PDGF-B markedly diminished, and in some experiments
completely abrogated, the migratory response [normoxic
migration 0.24 ± 0.19) (P < 0.0001) and hypoxic migra-
tion 0.18 ± 0.17 (P < 0.05), both fold of migration stimu-
lated by conditioned medium not preincubated with anti-
body]. Preincubation of conditioned media with IgG did
not decrease migration of cells compared to conditioned
medium alone (mean 1.5-fold increase in migrated cells
compared to control) (N = 2) (data not shown). To deter-
mine whether increased PDGF-B bioactivity in medium
conditioned by hypoxic endothelial cells merely reflected
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Fig. 6. Hypoxia increases specific binding ca-
pacity without increasing total cellular re-
ceptors. (A) Immunoblot for platelet-derived
growth factor (PDGF)-b receptor in whole
cell lysates from mesangial cells subjected to
hypoxia (H) or maintained in normoxia (N)
for the indicated durations. (B) Binding stud-
ies were conducted in mesangial cells under
normoxic or hypoxic conditions. Similar re-
sults were seen in three other independent
experiments.
a greater number of cells, we assessed cell number by de-
termining total cellular protein or by counting cells. Total
cellular protein was 15% to 37% lower, and cell counts
12% to 21% lower in hypoxic cells compared to normoxic
controls. Thus, hypoxia increases PDGF-B production on
a per cell basis in endothelial cells.
To investigate whether the enhanced hypoxic mesan-
gial cell responses are mediated by HIF-1a, cells were
treated with cobalt chloride or desferrioximine, and
migration in response to endothelial cell-conditioned
medium determined. Neither cobalt chloride- or
desferrioximine-treated cells showed an increase in mi-
gration compared to control cells (227 control cells vs. 176
cobalt chloride-treated, or 192 desferrioximine-treated
cells).
Hypoxia increases membrane-bound PDGF-b receptors
and ligand affinity
Finally, we wanted to study the mechanism underly-
ing enhanced PDGF-B responsiveness in hypoxic mesan-
gial cells. We performed immunoblots for the PDGF-b
receptor on whole cell lysates from cells exposed to
hypoxia for increasing durations and from normoxic
time-matched controls. As shown in Figure 6A, total cel-
lular b receptor levels were similar in normoxic cells and
cells exposed to as long 32 hours of hypoxia. We then per-
formed saturation binding studies to determine whether
hypoxia changes specific binding capacity. In hypoxic
cells, specific binding capacity was increased (Fig. 6B),
with a significant mean 2.3-fold increase compared to nor-
moxic cells (N = 4) (P ≤ 0.05).
DISCUSSION
We have demonstrated that hypoxia increases
glomerular capillary endothelial cell PDGF transcripts
and protein. We also report for the first time that hy-
poxia significantly amplifies the mitogenic and prolifer-
ative response of mesangial cells to exogenous PDGF.
Furthermore, more hypoxic mesangial cells migrate in re-
sponse to conditioned medium from hypoxic endothelial
cells than normoxic mesangial cells do when cultured with
medium from normoxic endothelial cells. The enhanced
migration of the hypoxic cells is markedly decreased in
the presence of PDGF-B neutralizing antibody. While hy-
poxia does not alter total cellular PDGF-b receptor lev-
els, specific binding capacity is increased in hypoxic cells.
These results demonstrate that hypoxia is a mediator of
PDGF-B paracrine interactions between glomerular cap-
illary endothelial and mesangial cells.
PDGF-B is critically important for vessel formation
and glomerulogenesis during fetal life, as demonstrated
by microaneurysm formation in capillary beds and the
complete absence of mesangial cells in PDGF-B null mice
[1]. Fetal mesangial cells themselves produce PDGF-B,
which could act in an autocrine fashion. However, we
did not observe an increase in proliferation of mesan-
gial cells when they were stimulated with medium con-
ditioned from hypoxic mesangial cells (data not shown),
and our results are consistent with a previous report sug-
gesting that mesangial cell PDGF-B is not increased by
hypoxia [33]. Most importantly, the studies from Lin-
dahl et al [3] and Bjarnegard et al [5] have demonstrated
that endothelial cells are the important source of PDGF-
B during glomerulogenesis. However, the regulation of
glomerular capillary endothelial cell PDGF-B during re-
nal organogenesis has not been well studied. Our studies
show that hypoxia is a modulator of glomerular endothe-
lial PDGF-B. We additionally show that hypoxia also
exaggerates the mesangial response to this important
cytokine. The relevance of our in vitro studies is sup-
ported by the in vivo studies by Freeburg et al [12, 13] in
the developing postnatal murine kidney. Staining for the
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chemical marker pimonidazole hydrochloride, which
forms detectable protein adducts only under severely hy-
poxic conditions (<10 mm Hg O2), was positive in the
outer cortex, albeit not as strongly positive as in the
tubules of the inner cortex. Using this indirect marker
of hypoxia, their results suggest that low oxygen tension
is present in the nephrogenic cortex, although the pre-
cise level of tissue oxygen is not known, and studies in
embryonic kidneys, with potentially even lower levels of
oxygen tension than in newborn kidneys, have not yet
been reported.
Our findings may be relevant not only to the develop-
ing kidney, but also to disease states of the mature kid-
ney. Endothelial cell damage occurs in many glomerular
diseases. In cases of microthrombus formation, it is pos-
sible that endothelial cells downstream of the thrombus
become hypoxic and might therefore increase their pro-
duction of PDGF-B. In other forms of endothelial cell
injury, however, it is less clear whether the endothelial
cells themselves become hypoxic. Nevertheless, disrup-
tion of the glomerular microvasculature might be pre-
dicted to result in at least some degree of glomerular
hypoxia [24]. In that regard, the impact of hypoxia on
mesangial cell response to cytokines important in the de-
velopment of glomerulosclerosis, such as PDGF-B, has
not been studied. We have demonstrated that hypoxia
up-regulates PDGF-mediated cellular proliferation, an
important early step in the development of many
glomerular diseases. We are currently investigating
whether hypoxia similarly enhances matrix production,
the hallmark of glomerulosclerosis. While much investi-
gation properly has focused on the inhibition of PDGF-
B production to limit the degree of sclerosis, our results
suggest that additionally abrogating the exaggerated re-
sponse of hypoxic mesangial cells to PDGF-B might
prove to be a beneficial adjuvant strategy in treating
glomerular diseases.
A number of questions arise from our studies. Al-
though hypoxia modestly stimulates glomerular endothe-
lial PDGF-B, we do not know whether this is a direct
effect, or whether hypoxia stimulates other effectors
which then activate the PDGF-B gene. In regard to a di-
rect effect, nuclear run-off studies would provide formal
proof for a transcriptional up-regulation of the PDGF-
B gene suggested by our actinomycin D experiments.
In investigating potential transactivators, we did not de-
tect increased nuclear levels of HIF-1a, despite putative
binding sites in the PDGF-B promoter. We previously
showed that NF-kB, another hypoxia-regulated transac-
tivator, increases endothelial PDGF-B [28]. However,
levels of NF-kB, as well as another oxygen-sensitive
PDGF-B transcription factor c-jun, were not different
between normoxic and hypoxic cells (data not shown).
Since this short list is by no means exhaustive, promoter
reporter studies interrupting the PDGF-B gene promoter
would be helpful in identifying the mediator(s) stimu-
lated by hypoxia. Second, it seems likely that hypoxia-
independent factors regulate endothelial PDGF-B ex-
pression during development, but the identity of these
other modulators is unknown. TGF-b [8] and bFGF [9]
are both important developmental cytokines that regu-
late PDGF-B, and since they are present during renal
organogenesis, would be reasonable candidates. Third,
the mechanism(s) responsible for the enhanced mesan-
gial cell responses to hypoxia remains to be defined fully.
Our results show that hypoxia does not increase steady-
state basal levels of the PDGF-b receptor, but in PDGF-
B–stimulated hypoxic cells, specific binding capacity is
increased. We are currently investigating whether hy-
poxia itself increases redistribution of receptors to the
membrane or whether hypoxia alters degradation of the
ligand-bound hypoxic receptor. Additionally, how hy-
poxia influences the intracellular signaling pathways lead-
ing to increased migration and proliferation remains to
be explored.
CONCLUSION
We have provided evidence for a hypoxia-mediated
pathway that may be important in both fetal life and
the pathogenesis of disease in the adult. The current
understanding of glomerular vascular development is
that relatively low oxygen tension stimulates podocytes
to express VEGF which recruits endothelial cells to
the glomerulus. We propose that relatively low oxy-
gen tension further contributes to glomerulogenesis by
amplifying the PDGF-B paracrine interactions between
glomerular endothelial and mesangial cells. Hypoxia in-
creases glomerular capillary endothelial expression of
PDGF-B which attracts mesangial cells and hypoxia aug-
ments the migratory and proliferative response of mesan-
gial cells to PDGF-B. Once vessel formation is complete,
relatively low oxygen tension, and presumably also the
amplification of the PDGF-B paracrine system, ceases.
In diseases of the adult, however, hypoxia resulting from
insults to the endothelium continues unabated, contribut-
ing to pathogenic mechanisms, including those mediated
by PDGF-B.
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